0001209191-23-009115.txt : 20230214 0001209191-23-009115.hdr.sgml : 20230214 20230214161934 ACCESSION NUMBER: 0001209191-23-009115 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230210 FILED AS OF DATE: 20230214 DATE AS OF CHANGE: 20230214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Angotti Vincent J. CENTRAL INDEX KEY: 0001700225 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 23629704 MAIL ADDRESS: STREET 1: C/O ACELRX PHARMACEUTICALS, INC. STREET 2: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25821 INDUSTRIAL BOULEVARD STREET 2: SUITE 400 CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 25821 INDUSTRIAL BOULEVARD STREET 2: SUITE 400 CITY: HAYWARD STATE: CA ZIP: 94545 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-10 0 0001427925 ACELRX PHARMACEUTICALS INC ACRX 0001700225 Angotti Vincent J. C/O ACELRX PHARMACEUTICALS, INC. 25821 INDUSTRIAL BLVD., SUITE 400 HAYWARD CA 94545 1 1 0 0 Chief Executive Officer Common Stock 2023-02-10 4 A 0 19500 0.00 A 68860 D Common Stock 2023-02-11 4 F 0 3321 1.68 D 65539 D Stock Option (Right to Buy) 1.76 2023-02-10 4 A 0 117000 0.00 A 2033-02-09 Common Stock 117000 117000 D The restricted stock units shall vest in three equal consecutive annual installments on February 10, 2024, February 10, 2025 and February 10, 2026. Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. On February 10, 2023, the reporting person was granted an option to purchase 117,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. /s/ Martha Adler, Attorney-In-Fact 2023-02-14